Immune dysregulation and potential targeted therapy in myelodysplastic syndrome

Myelodysplastic syndrome (MDS) is a heterogeneous group of clonal hematological diseases and a high risk for transformation to acute myeloid leukemia (AML). The identification of key genetic alterations in MDS has enhanced our understanding of the pathogenesis and evolution. In recent years, it has...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiaoying, Yang, Xingcheng, Ma, Ling, Zhang, Yicheng, Wei, Jia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399277/
https://www.ncbi.nlm.nih.gov/pubmed/37547364
http://dx.doi.org/10.1177/20406207231183330

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399277/
https://www.ncbi.nlm.nih.gov/pubmed/37547364
http://dx.doi.org/10.1177/20406207231183330

Ejemplares similares